Erythrodermic psoriasis and human immunodeficiency virus: association and therapeutic challenges

AUTOR(ES)

Valenzuela, Fernando, Fernández, Javier, Sánchez, Margarita, Zamudio, Andrea

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2018-06

RESUMO

Abstract: Erythrodermic psoriasis is a rare but severe type of psoriasis that may be triggered by human immunodeficiency virus infection. We describe the case of a 65-year-old male patient with chronic psoriasis who presents an exacerbation of his condition over a period of two weeks. Because of the severity of his case and subsequent need for systemic therapy, human immunodeficiency virus enzyme immunoassay was performed and tested positive. He thus began antiretroviral therapy combined with acitretin, showing good clinical response after 8 weeks of treatment. There is little evidence regarding the management of erythrodermic psoriasis associated with HIV infection, so antiretroviral therapy and systemic retinoid remain as the first-line treatment.

Documentos Relacionados

• Convicting a human tumor virus: Guilt by association?
• Wet wrap dressings as a rescue therapy option for erythrodermic psoriasis
• DC-SIGN Interactions with Human Immunodeficiency Virus: Virus Binding and Transfer Are Dissociable Functions
• Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.
• Human immunodeficiency virus infection and its association with sarcopenia